• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经治疗的肝细胞癌的影像学表现。

Imaging appearance of treated hepatocellular carcinoma.

作者信息

Agnello Francesco, Salvaggio Giuseppe, Cabibbo Giuseppe, Maida Marcello, Lagalla Roberto, Midiri Massimo, Brancatelli Giuseppe

机构信息

Francesco Agnello, Giuseppe Salvaggio, Roberto Lagalla, Massimo Midiri, Giuseppe Brancatelli, Section of Radiological Sciences, DIBIMEF, University of Palermo, 90127 Palermo, Italy.

出版信息

World J Hepatol. 2013 Aug 27;5(8):417-24. doi: 10.4254/wjh.v5.i8.417.

DOI:10.4254/wjh.v5.i8.417
PMID:24023980
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3767840/
Abstract

Surgical resection and imaging guided treatments play a crucial role in the management of hepatocellular carcinoma (HCC). Although the primary end point of treatment of HCC is survival, radiological response could be a surrogate end point of survival, and has a key role in HCC decision-making process. However, radiological assessment of HCC treatment efficacy is often controversial. There are few doubts on the evaluation of surgical resection; in fact, all known tumor sites should be removed. However, an unenhancing partial linear peripheral halo, in most cases, surrounding a fluid collection reducing in size during follow-up is demonstrated in successfully resected tumor with bipolar radiofrequency electrosurgical device. Efficacy assessment of locoregional therapies is more controversial and differs between percutaneous ablation (e.g., radiofrequency ablation and percutaneous ethanol injection) and transarterial treatments (e.g., conventional transarterial chemoembolization, transarterial chemoembolization with drug eluting beads and radioembolization). Finally, a different approach should be used for new systemic agent that, though not reducing tumor mass, could have a benefit on survival by delaying tumor progression and death. The purpose of this brief article is to review HCC imaging appearance after treatment.

摘要

手术切除和影像引导治疗在肝细胞癌(HCC)的管理中起着关键作用。虽然HCC治疗的主要终点是生存,但放射学反应可能是生存的替代终点,并且在HCC决策过程中起关键作用。然而,HCC治疗疗效的放射学评估常常存在争议。对于手术切除的评估几乎没有疑问;事实上,所有已知的肿瘤部位都应被切除。然而,在使用双极射频电外科设备成功切除的肿瘤中,在大多数情况下,会显示出一个无强化的部分线性周边晕圈,其围绕着一个在随访期间尺寸缩小的液性聚集区。局部区域治疗的疗效评估更具争议性,在经皮消融(如射频消融和经皮乙醇注射)和经动脉治疗(如传统经动脉化疗栓塞、载药微球经动脉化疗栓塞和放射性栓塞)之间存在差异。最后,对于新的全身治疗药物应采用不同的方法,这些药物虽然不会缩小肿瘤体积,但可能通过延缓肿瘤进展和死亡而对生存有益。这篇简短文章的目的是回顾治疗后HCC的影像学表现。

相似文献

1
Imaging appearance of treated hepatocellular carcinoma.经治疗的肝细胞癌的影像学表现。
World J Hepatol. 2013 Aug 27;5(8):417-24. doi: 10.4254/wjh.v5.i8.417.
2
Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.肝细胞癌的局部区域治疗:外科医生视角的批判性综述
Ann Surg. 2002 Apr;235(4):466-86. doi: 10.1097/00000658-200204000-00004.
3
Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how?局部放射治疗肝癌;何时、何地以及如何治疗?
Cancer Treat Rev. 2012 Feb;38(1):54-62. doi: 10.1016/j.ctrv.2011.05.002. Epub 2011 Jul 2.
4
Transarterial chemoembolization using drug eluting beads and subsequent percutaneous MR-guided radiofrequency ablation in the therapy of intermediate sized hepatocellular carcinoma.使用载药微球的经动脉化疗栓塞术及随后在中大型肝细胞癌治疗中经皮磁共振引导下的射频消融术
Eur J Radiol. 2014 Oct;83(10):1793-8. doi: 10.1016/j.ejrad.2014.06.031. Epub 2014 Jul 6.
5
Transarterial chemoembolization for hepatocellular carcinoma: A review of techniques.肝细胞癌的经动脉化疗栓塞术:技术综述
World J Hepatol. 2014 Dec 27;6(12):844-50. doi: 10.4254/wjh.v6.i12.844.
6
Imaging findings of liver resection using a bipolar radiofrequency electrosurgical device--initial observations.使用双极射频电外科设备进行肝切除的影像学发现——初步观察。
Eur J Radiol. 2012 Apr;81(4):663-70. doi: 10.1016/j.ejrad.2011.01.015. Epub 2011 Feb 8.
7
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma.射频消融联合载药微球经动脉化疗栓塞治疗单个大肝细胞癌
Dig Liver Dis. 2015 Mar;47(3):242-8. doi: 10.1016/j.dld.2014.12.007. Epub 2014 Dec 13.
8
Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma.肝硬化合并孤立性大肝细胞癌患者行肝切除与射频消融联合经动脉化疗栓塞术的比较
J Vasc Interv Radiol. 2017 Nov;28(11):1512-1519. doi: 10.1016/j.jvir.2017.06.016. Epub 2017 Jul 19.
9
10
Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.早期或极早期肝细胞癌患者的管理:一项网络荟萃分析尝试
Cochrane Database Syst Rev. 2017 Mar 28;3(3):CD011650. doi: 10.1002/14651858.CD011650.pub2.

引用本文的文献

1
LI-RADS TRA V2024: innovations in imaging assessment of hepatocellular carcinoma response to locoregional therapies.肝脏影像报告和数据系统(LI-RADS)TRA V2024:肝细胞癌对局部区域治疗反应的影像评估创新
Abdom Radiol (NY). 2025 Aug 27. doi: 10.1007/s00261-025-05110-8.
2
PET/MRI: pictorial review of hepatobiliary and pancreatic applications.PET/MRI:肝胆胰应用的影像学综述
Abdom Radiol (NY). 2025 Feb;50(2):875-901. doi: 10.1007/s00261-024-04548-6. Epub 2024 Sep 10.
3
[Ablation of liver tumors : From pre-interventional imaging to post-interventional assessment].[肝脏肿瘤消融:从介入前成像到介入后评估]
Radiologie (Heidelb). 2024 Jun;64(6):503-514. doi: 10.1007/s00117-024-01308-x. Epub 2024 May 23.
4
Multidisciplinary comprehensive treatment of massive hepatocellular carcinoma with hemorrhage: A case report and review of literature.巨大肝细胞癌伴出血的多学科综合治疗:一例报告并文献复习
World J Gastrointest Oncol. 2024 May 15;16(5):2225-2232. doi: 10.4251/wjgo.v16.i5.2225.
5
Telomerase-related advances in hepatocellular carcinoma: A bibliometric and visual analysis.端粒酶相关的肝细胞癌研究进展:文献计量学和可视化分析。
World J Gastroenterol. 2024 Mar 7;30(9):1224-1236. doi: 10.3748/wjg.v30.i9.1224.
6
Ethiodized oil as an imaging biomarker after conventional transarterial chemoembolization.碘化油作为常规经动脉化疗栓塞后的成像生物标志物。
Eur Radiol. 2024 May;34(5):3284-3297. doi: 10.1007/s00330-023-10326-7. Epub 2023 Nov 6.
7
Functional Imaging of Liver Cancer (FLIC): Study protocol of a phase 2 trial of 18F-DCFPyL PET/CT imaging for patients with hepatocellular carcinoma.肝癌功能成像(FLIC):18F-DCFPyL PET/CT 成像用于肝细胞癌患者的 2 期试验研究方案。
PLoS One. 2022 Nov 11;17(11):e0277407. doi: 10.1371/journal.pone.0277407. eCollection 2022.
8
Local-Regional Treatment of Hepatocellular Carcinoma: A Primer for Radiologists.肝细胞癌的局部区域治疗:放射科医生的入门指南。
Radiographics. 2022 Oct;42(6):1670-1689. doi: 10.1148/rg.220022.
9
Current Imaging Diagnosis of Hepatocellular Carcinoma.肝细胞癌的当前影像诊断
Cancers (Basel). 2022 Aug 18;14(16):3997. doi: 10.3390/cancers14163997.
10
Rim Enhancement after Technically Successful Transarterial Chemoembolization in Hepatocellular Carcinoma: A Potential Mimic of Incomplete Embolization or Reactive Hyperemia?经导管肝动脉化疗栓塞术后肿瘤环形强化:不完全栓塞或反应性充血的潜在假象?
Tomography. 2022 Apr 15;8(2):1148-1158. doi: 10.3390/tomography8020094.

本文引用的文献

1
Imaging assessment of hepatocellular carcinoma response to locoregional and systemic therapy.肝癌局部和系统治疗反应的影像学评估。
AJR Am J Roentgenol. 2013 Jul;201(1):80-96. doi: 10.2214/AJR.13.10706.
2
Assessment of treatment response in hepatocellular carcinoma: a review of the literature.肝癌治疗反应评估:文献综述。
Future Oncol. 2013 Jun;9(6):845-54. doi: 10.2217/fon.13.33.
3
Survival advantage of radiofrequency ablation for hepatocellular carcinoma: comparison with ethanol injection.肝细胞癌射频消融术的生存优势:与乙醇注射的比较。
Hepatogastroenterology. 2013 Sep;60(126):1399-404. doi: 10.5754/hge121270.
4
Assessment of response to sorafenib in advanced hepatocellular carcinoma using perfusion computed tomography: results of a pilot study.使用灌注 CT 评估索拉非尼治疗晚期肝细胞癌的疗效:一项初步研究的结果。
Dig Liver Dis. 2013 Sep;45(9):776-81. doi: 10.1016/j.dld.2013.03.004. Epub 2013 Apr 9.
5
Treatment of hepatocellular carcinoma: present and future.肝细胞癌的治疗:现状与未来。
Expert Rev Anticancer Ther. 2013 Apr;13(4):469-79. doi: 10.1586/era.13.21.
6
Imaging after percutaneous radiofrequency ablation of hepatic tumors: Part 2, Abnormal findings.经皮射频消融治疗肝肿瘤的影像学表现:第 2 部分,异常表现。
AJR Am J Roentgenol. 2013 Jan;200(1):194-204. doi: 10.2214/AJR.12.8479.
7
Imaging after percutaneous radiofrequency ablation of hepatic tumors: Part 1, Normal findings.经皮射频消融治疗肝肿瘤的影像学表现:第 1 部分,正常表现。
AJR Am J Roentgenol. 2013 Jan;200(1):184-93. doi: 10.2214/AJR.12.8478.
8
Established and novel imaging biomarkers for assessing response to therapy in hepatocellular carcinoma.用于评估肝细胞癌治疗反应的既定和新型成像生物标志物。
J Hepatol. 2013 Jan;58(1):169-77. doi: 10.1016/j.jhep.2012.08.022. Epub 2012 Aug 31.
9
Enhancement patterns of hepatocellular carcinoma after transarterial chemoembolization using drug-eluting beads on arterial phase CT images: a pilot retrospective study.经动脉化疗栓塞术(TAE)后应用载药微球的肝细胞肝癌动脉期 CT 增强模式:一项初步回顾性研究。
AJR Am J Roentgenol. 2012 Aug;199(2):349-59. doi: 10.2214/AJR.11.7563.
10
The road less traveled: importance of the lesser branches of the celiac axis in liver embolotherapy.少有人走的路:腹腔轴较小分支在肝栓塞治疗中的重要性。
Radiographics. 2012 Jul-Aug;32(4):1121-32. doi: 10.1148/rg.324115114.